findmyKOL

Ahad Fazelat, MD

Basic profile

Ophthalmology

ORCIDNone on fileNPI
RegionManchester, NH · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ahad Fazelat is an Ophthalmology physician. OpenAlex indexes 14 publications with 371 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

371citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

250 River Rd
Manchester, NH 031042423

Telephone

603-663-2020

Registry record last updated 21 Jul 2017.

View the NPPES registry record

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    99.2%
    Antineovascularisation agents99%
    Faricimab-svoa100%
    Part B, office-administered257 patients
    Prostaglandin Analog0.1%
    Latanoprost100%
    Part D17 patients

    + 4 more classes in this area

  • Cancer & immunology

    0.7%
    Vascular Endothelial Growth Factor Inhibitor0.7%
    Aflibercept80%Bevacizumab20%
    Part B, office-administered53 patients
    Calcineurin inhibitor0%
    Restasis100%
    Part D<11 patients
  • Cardiovascular

    0.1%
    Beta blocker0.1%
    Timolol Maleate100%
    Part D19 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”